Cell Therapy Manufacturing Market Global 2019 Analysis – by Size, Share, Trends, Top 10 Key Players Overview, Opportunity Assessment and Forecast to 2026
Cell therapy is a medical procedure which primarily used for the restoration of damaged tissue and has broad application in treating various infectious and chronic disease such as metabolic disorders, immune deficiency, tissue degradation, and cancer. Cell therapy is classified into two types’ i.e. autologous (one’s own body’s cells) and allogeneic (third party donor’s cells). Cell therapy technique has gained rapid adoption in recent past years as it is widely used to restore the lost function of tissues and cells rather than to developing a new organ. Recently, few cell therapies have been approved for a clinical trial. For instance, in 2013 a stage 2 clinical trial was completed for transplantation of bone marrow-derived stem cells in affected knee by rheumatoid arthritis. The growth of this technique is also increased due to the involvement of government agencies. For instance, innovate U.K. 2014 report showed that the government agreed to fund US$15.3 million in cell therapy manufacturing market.
To get a holistic SAMPLE of the report including the table of contents, please click https://www.coherentmarketinsights.com/insight/request-sample/1728
The rising number of surgical procedure around the globe along with a growing number of trauma and accident cases are predominantly fueling the market growth. For instance, according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell transplants are carried out annually worldwide for various surgeries. Moreover, stem cell transplantation has emerged as promising medical therapy for patients suffering from highly advanced stages disease like blindness, Alzheimer’s, autism, arthritis, cancer, cerebral palsy, diabetes, etc. Key biopharmaceutical companies are majorly investing in research for cell therapy. For instance, Longeveron LL, a biopharmaceutical company received a US$ 750,000 grant from the Maryland Technology Development Corporation (TEDCO) in 2018 for stem cell therapy research. These agreement and government financial support are further augmenting the growth of the cell therapy market. On the other hand, the stringent rules and regulations along with the health safety issues over cell therapy treatment are anticipated to limit the market growth.
From the geographical point of view, the global cell therapy market is studied across the region of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is dominating the overall market and is likely to maintain its dominance over the forecast period. The growth in the North America market primarily depends on the growing number of surgeries in the region as well as the development of advanced therapy. According to the National Health Statistics Report by the Centers for Disease Control & Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were performed in the U.S. in 2011.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1728
Moreover, the Asia Pacific market is assumed to gain significant growth in the overall cell therapy manufacturing market in the upcoming years
Marginal market share would be grabbed by the local players entering into market owing to less stringent regulatory requirements and increasing number of customer pool prone to suffering from various chronic disease such as cancer, HIV, hepatitis, etc. hence the advent of cell therapy can offer enhanced solutions to the patient at the marginally lower cost.
The key player operating in the global cell therapy manufacturing market include Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec. Key players are adopting smart strategies such as collaborations, introduction of new technologies and devices to expand their position in the market. For instance, in 2014, ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell-derived islet for the treatment of type 1 diabetes.
Browse Research Report At https://www.coherentmarketinsights.com/ongoing-insight/cell-therapy-manufacturing-market-1728
By Therapy Type
- Allogeneic Cell Therapy
- Autologous Cell Therapy
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- 3D Technology
- IPSC’s (Induced pluripotent stem cell)
- Bone marrow
- Umbilical cord
- Adipose tissue
- Neural stem
- North America
- Latin America
- Asia Pacific
- Middle East
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire